Year: 2026
Type: article
Abstract: Precision-based percutaneous coronary intervention (PCI) integrates contemporary strategies across the pre-, intra-, and post-procedural phases to improve outcomes and minimize complications. Emerging evidence underscores the value of these strategies in reducing adverse events and improving procedural efficiency. While artificial intelligence and pharmacogenomics hold long-term promise for enhancing personalization, their clinical utility in PCI remains in the early stages of development.
Source: npj Cardiovascular Health
Institutions: Emory University, University of Mississippi Medical Center, Liaquat University of Medical & Health Sciences, Baylor College of Medicine, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, Case Western Reserve University, Michael E. DeBakey VA Medical Center, University of Missouri–Kansas City, University of Florida Health, University of Florida, NYU Langone Health, New York University, Yale University, Mount Sinai Hospital, University of California, San Francisco, Cardiovascular Research Foundation
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,590
OpenAlex ID: W7140130031